Dr. Agarwal's Eye Hospital Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Adil Agarwal

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	5.9yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	less than a year
Yönetim Kurulu ortalama görev süresi	4.4yrs

Son yönetim güncellemeleri

Recent updates

CEO

Adil Agarwal (41 yo)

5.9yrs

Görev süresi

₹300,000

Tazminat

Dr. Adil Agarwal serves as Chief Executive Officer at Dr. Agarwal's Eye Hospital Limited and serves as its Whole -Time Director from 2024. Dr. Agarwal serves as Chief Executive Officer at Dr Agarwal’s Heal...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Amar Agarwal	Founder	31.1yrs	₹23.62m	Veri yok
Athiya Agarwal	Founder & Whole Time Director	no data	₹9.20m	Veri yok
Yashwanth Venkat	Interim Chief Financial Officer	less than a year	₹5.07m	Veri yok
Meenakshi Jayaraman	Company Secretary & Compliance Officer	3.4yrs	₹1.60m	Veri yok
Adil Agarwal	CEO & Whole -Time Director	no data	₹300.00k	Veri yok
Suhasini K	Head of Human Resource	no data	Veri yok	Veri yok
Aman Joshi	Head of Digital Marketing	less than a year	Veri yok	Veri yok
N. Ugandhar	Senior Vice President of International Operations of BD and M&A	less than a year	Veri yok	Veri yok
Nandha Kumar	Senior Vice President of Operations of South & East India	less than a year	Veri yok	Veri yok
Terence Leo Seqi	General Manager of Projects	no data	Veri yok	Veri yok

0.6yrs

Ortalama Görev Süresi

47yo

Ortalama Yaş

Deneyimli Yönetim: 526783 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.6 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Amar Agarwal	Founder	31.1yrs	₹23.62m	Veri yok
Athiya Agarwal	Founder & Whole Time Director	31yrs	₹9.20m	Veri yok
Adil Agarwal	CEO & Whole -Time Director	5.9yrs	₹300.00k	Veri yok
Venkatraman Balakrishnan	Independent Director	2.9yrs	₹100.00k	Veri yok
Latha Ramanathan	Independent Director	1yr	Veri yok	Veri yok
Shiv Agrawal	Non-Executive Independent Director	less than a year	Veri yok	Veri yok

4.4yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 526783 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.4 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/05/23 03:27
Gün Sonu Hisse Fiyatı	2025/05/23 00:00
Kazançlar	2024/12/31
Yıllık Kazançlar	2024/03/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Dr. Agarwal's Eye Hospital Limited 2 Bu analistlerden 0, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Kameswari V. S. Chavali	FirstCall Research
Tushar Manudhane	Motilal Oswal Securities Ltd.

Dr. Agarwal's Eye Hospital Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Dr. Agarwal's Eye Hospital Limited Appoints Yashwanth Venkat as Key Managerial Personnel

Dr. Agarwal's Eye Hospital Limited Appoints Aman Joshi as Head of Digital Marketing

Less than half of directors are independent

Dr. Agarwal's Eye Hospital Limited Announces Cessation of Sanjay Anand as Independent Director

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Aug 26, 2024

Dr. Agarwal's Eye Hospital Limited Appoints Latha Ramanathan as an Additional Director

Recent updates

Dr. Agarwal's Eye Hospital Limited to Report Q4, 2025 Results on May 28, 2025

New minor risk - Financial position

Third quarter 2025 earnings released: EPS: ₹22.13 (vs ₹20.09 in 3Q 2024)

Dr. Agarwal's Eye Hospital Limited to Report Q3, 2025 Results on Feb 14, 2025

Investor sentiment deteriorates as stock falls 26%

Dr. Agarwal's Eye Hospital Limited Announces Interim Dividend for the Financial Year 2024-25, Payable on or Before November 25, 2024

Dr. Agarwal's Eye Hospital Limited Appoints Yashwanth Venkat as Key Managerial Personnel

Dr. Agarwal's Eye Hospital Limited to Report Q2, 2025 Results on Oct 29, 2024

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 19%

Dr. Agarwal's Eye Hospital Limited Appoints Aman Joshi as Head of Digital Marketing

Less than half of directors are independent

Dr. Agarwal's Eye Hospital Limited Announces Cessation of Sanjay Anand as Independent Director

Dr. Agarwal's Eye Hospital Limited Approves Dividend for the Year Ended March 31, 2024

Upcoming dividend of ₹2.50 per share

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Aug 26, 2024

New minor risk - Financial position

First quarter 2025 earnings released: EPS: ₹30.02 (vs ₹24.55 in 1Q 2024)

Dr. Agarwal's Eye Hospital Limited to Report Q1, 2025 Results on Jul 25, 2024

Dr. Agarwal's Eye Hospital Limited Appoints Latha Ramanathan as an Additional Director

Full year 2024 earnings released: EPS: ₹98.64 (vs ₹78.55 in FY 2023)

Dr. Agarwal's Eye Hospital Limited Recommends Final Dividend for the Financial Year 2023-2024

Dr. Agarwal's Eye Hospital Limited to Report Q3, 2024 Results on Jan 18, 2024

Third quarter 2024 earnings released: EPS: ₹20.09 (vs ₹10.77 in 3Q 2023)

Investor sentiment improves as stock rises 20%

Upcoming dividend of ₹2.50 per share at 0.2% yield

Second quarter 2024 earnings released: EPS: ₹26.79 (vs ₹19.30 in 2Q 2023)

Dr. Agarwal's Eye Hospital Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before 18 November 2023

Dr. Agarwal's Eye Hospital Limited Approves Dividend for the Year Ended March 3 1, 2023

Upcoming dividend of ₹3.00 per share at 0.1% yield

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Sep 21, 2023

Investor sentiment improves as stock rises 22%

New minor risk - Financial position

First quarter 2024 earnings released: EPS: ₹24.55 (vs ₹19.38 in 1Q 2023)

Investor sentiment improves as stock rises 21%

Dr. Agarwal's Eye Hospital Limited to Report Q1, 2024 Results on Aug 04, 2023

Investor sentiment improves as stock rises 26%

Dr. Agarwal's Eye Hospital Limited Recommends Final Dividend for the Fiscal Year 2023

Full year 2023 earnings released: EPS: ₹78.55 (vs ₹51.29 in FY 2022)

Investor sentiment improves as stock rises 25%

Investor sentiment deteriorates as stock falls 22%

Third quarter 2023 earnings released: EPS: ₹10.77 (vs ₹17.34 in 3Q 2022)

Dr. Agarwal's Eye Hospital Limited to Report Nine Months, 2023 Results on Jan 21, 2023

Investor sentiment improved over the past week

Dr. Agarwal's Eye Hospital Limited to Report Q2, 2023 Results on Oct 28, 2022

Now 21% undervalued

Dr. Agarwal's Eye Hospital Limited Approves Final Dividend for Financial Year Ended March 31, 2022

Investor sentiment improved over the past week

Upcoming dividend of ₹3.00 per share

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Sep 14, 2022

First quarter 2023 earnings released: EPS: ₹19.38 (vs ₹1.54 loss in 1Q 2022)

Dr. Agarwal's Eye Hospital Limited to Report Q1, 2023 Results on Aug 04, 2022

Full year 2022 earnings released: EPS: ₹51.29 (vs ₹3.06 loss in FY 2021)

Dr. Agarwal's Eye Hospital Limited Recommends Dividend for the Financial Year 2022

Less than half of directors are independent

Dr. Agarwal's Eye Hospital Limited Announces Resignation of T.R. Ramasubramanian as Independent Director

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

TPG Reportedly in Advanced Talks to Acquire 40% in Dr Agarwal's Health Care

Investor sentiment improved over the past week

Company Secretary & Compliance Officer Jully Jivani has left the company

First quarter 2022 earnings released: ₹1.54 loss per share (vs ₹16.19 loss in 1Q 2021)

Full year 2021 earnings released: ₹3.06 loss per share (vs ₹29.11 profit in FY 2020)

New 90-day high: ₹302

Dr. Agarwal's Eye Hospital Limited to Report Q3, 2021 Results on Jan 25, 2021

New 90-day high: ₹275

New 90-day high: ₹274